Notably, FGF21 is considered an established biomarker of human mitochondrial myopathy (Suomalainen, 2013), and as expected, plasma FGF21 levels were also increased in MERRF patients (8‐fold, Fig 4K). Here, FGF21 is linked to MERRF.